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Abstract: Skin cancer is the most prevalent cancer in the light-skinned population and it is generally caused by exposure to ultraviolet 
light. Early detection of skin cancer has the potential to reduce mortality and morbidity. There are many diagnostic technologies and 
tests to diagnose skin cancer. However many of these tests are extremely complex and subjective and depend heavily on the experience 
of the clinician. To obviate these problems, image processing techniques, a neural network system (NN) and a fuzzy inference system 
were used in this study as promising modalities for detection of different types of skin cancer. The accuracy rate of the diagnosis of skin 
cancer by using the hierarchal neural network was 90.67% while using neuro-fuzzy system yielded a slightly higher rate of accuracy of 
91.26% in diagnosis skin cancer type. The sensitivity of NN in diagnosing skin cancer was 95%, while the specificity was 88%. Skin 
cancer diagnosis by neuro-fuzzy system achieved sensitivity of 98% and a specificity of 89%.
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Introduction
Skin cancer is a major public health problem. Skin 
cancer is divided into non melanoma skin cancer 
(NMSC) and melanoma skin cancer (MM) (Fig. 1). 
Non  melanoma  skin  cancer  (MMSC)  is  the  most 
prevalent cancer among light-skinned population.1 
It is divided into basal cell carcinoma (BCC) (75%), 
squamous cell carcinoma (SCC) (24%), and other 
rare  types  (1%)  such  as  sebaceous  carcinoma. 
(Fig. 1).
The  age-standardized  incidence  rates  per  year 
of basal cell carcinoma is 175 per 100,000 in men 
and 124 per 100,000 in women.1 Rates of squamous 
cell cancer are 63.1 per 100,000 in men and 22.5 
per 100,000 women.1 Non melanoma skin cancer is 
  seldom lethal, but if advanced can cause severe dis-
figurement and morbidity.
The  critical  factor  in  assessment  of  patient 
  prognosis  in  skin  cancer  is  early  diagnosis.  There 
are many methods to diagnose non-melanoma skin 
cancer  (NMSC)2–5  such  as  physical  and    clinical 
examination,  biopsy,  molecular  markers,  ultra 
  sonography,  Doppler,  optical  coherence  tomogra-
phy, dermoscopy, spectroscopy, fluoresence imaging, 
  confocal   microscopy, positron emission tomography, 
  computed tomography, magnetic resonance imaging, 
terahertz imaging, and electrical impedance. All these 
  methods have different accuracy rates, sensitivity and 
specificity  in  diagnosing  NMSC.  Melanoma  skin 
cancer  is  divided  into:  superficial  spreading  mela-
noma,   nodular melanoma, lentigo maligna melanoma 
and acral   lentiginous melanoma. (Fig. 1). More than 
60,000 people in the United States were diagnosed 
with invasive   melanoma in recent years, and more 
than 8000 Americans died of the disease.6
The single most promising strategy to cut acutely 
the mortality rate from melanoma is early detection. 
Attempts to improve the diagnostic accuracy of mela-
noma  have  spurred  the  development  of  innovative 
in-vivo imaging modalities, including total body pho-
tography, dermoscopy, automated diagnostic system 
and reflectance confocal microscopy. Neural networks 
(NN) are a large class of models developed in the cog-
nitive sciences, the structure of which was inspired 
by that of the nervous system of living beings. Cer-
tain applications of NN in medicine have led to sig-
nificant improvement in medical decision making,7–10 
including pigmented skin lesions and skin cancer,11–16 
however, the fuzzy system was not addressed previ-
ously. Fuzzy logic is a form of multi-valued logic that 
deals with reasoning that is approximate rather than 
precise.
This paper proposes a system to make the com-
puter automatically locate the tumor location in 
the  image  and  calculate  relevant  features:  such 
features can be used to determine the type of skin 
cancer.
Neural  network  models  have  been  studied  and 
used in this research. In general each network con-
sists of three layers, input, hidden, and output layer. 
The   proposed system composed of four NN built as 
a hierarchal NN system with Back Propagation learn-
ing. Each NN has an input layer, two hidden layers, 
and output layer. Many transfer functions are included 
in the neural-network; neurons can use any differ-
entiable  transfer  function  to  generate  their  output.   
Log-sigmoid transfer functions have often been used 
by multilayer networks, it generates outputs between 
0 and 1 as the neuron’s net input goes from negative 
to positive infinity. Alternatively, multilayer networks 
can use the tan-sigmoid transfer   function; this function 
generates outputs from negative to positive infinity. 
In this study we used tan-sigmoid transfer function, 
in order to generate outputs between negative infinity 
to positive infinity.
The  fuzzy  logic  inference  system  used  in  this 
research  was  intended  to  make  the  differentiation 
results between skin cancer types more accurate. It is 
based on the nature of fuzzy human thinking. After 
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testing  all  images  by  using  hierarchal  neural  net-
work, NN results are entered into a fuzzy logic infer-
ence system to improve cancer diagnosis. There are 
three fuzzy logic inference systems, FIZ1, FIZ2, &   
FIZ3.
Methods
reprocessing of data and features 
extraction
There are many types of the skin cancer; each type 
has a different color, size and features. Figure 2 shows 
types of skin cancer that are studied in this research:
Many skin features may have impact on digital 
images like hair and color, and other impacts such as 
lightness, and type of the scanner or digital camera. 
Images are processed to have the following starting 
features:
•	 The same dimension (width and height)
•	 Removing hair if any: using a filter 
•	 Color filtration through BLURE filter
•	 Matching image colors and brightness to be corre-
spondent to images in the collection for high accu-
racy: using levels. Normalization of images was 
done.
After selecting our testing images, the above four 
steps for each image are performed manually using 
Adobe Photoshop in order to have same similar ranges 
of colors; this makes it easier for VB.NET program to 
extract the correct place of the tumor. Figure 3 shows 
the image before and after performance of the nor-
malization steps.
The  next  step  is  to  enter  the  images  into  a 
VB.NET program to read the location of the tumor 
using  color  detection.  After  the  color  range  of 
the image collection is checked, pixels that have 
a  red  color  intensity  value  of  less  than  150,  a 
green color intensity value of less than 150, and 
a blue color intensity value of less than 150 are 
found to be the tumor location, so all the locations 
with white area will be the tumor. Figure 4 shows 
the  result  of  processing  the  image  in  VB.NET   
program.
After  performing  steps  mentioned  above, 
VB.NET software starts reading and finding the 20 
features of the images that will be entered to the 
neural network. All these features will be saved in 
separate file.
The  features  extracted  from  images  using  the 
VB.NET code are shown in Table 1.
Each feature of the image is calculated in a differ-
ent way.11,18 These features are divided into:
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•	 Area  Features:  Irregularity  index  and  Percent 
asymmetry features.
•	 Color Features: all remaining features.
After finding features for the study images sample, 
related data are analyzed statistically. First nineteen 
images from melanoma and non-melanoma skin can-
cers were taken and their features were compared. We 
found that color features are more dependable fea-
tures than area features. As shown in Figures 5 and 
6,  which  describe  area  features,  irregularity  index 
and  border  asymmetry,  both  melanoma  and  non- 
melanoma skin cancers are close together, and have 
Image before processing
Image after processing using VB.NET program
Figure 4. Processing image using VB.NeT program.
Table 1. Skin cancer images features.
Feature Feature description
F1 Irregularity index
F2 Percent asymmetry
F3 red color variance
F4 green color variance
F5 Blue color variance
F6 red relative chromaticity
F7 green relative chromaticity
F8 Blue relative chromaticity
F9 Spherical color coordinates (L)
F10 Spherical color coordinates (α)
F11 Spherical color coordinates (β)
F12 Color coordinates (L*)
F13 Color coordinates (a*)
F14 Color coordinates (b*)
F15 red ratio
F16 green ratio
F17 Blue ratio
F18 Difference in lightness
F19 Difference in chroma
F20 Difference in color
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many intersecting points between them, therefore we 
could not depend only on area features.
In general, the color feature is the most depend-
able feature in recognizing cancer, especially the 
red color, and we can see in Figure 7 that there is a 
difference between melanoma and non-melanoma 
in the red variance feature, so we can depend on this 
feature to recognize the type of the skin cancer.
F9 is another example of a dependable feature. 
With the spherical color coordinates L, as shown in 
Figure 8, it is seen that the value of L is different 
between the two main cancer types: melanoma and 
non-melanoma.
Figures 9 shows the red ratio feature, as we can 
see  no  intersection  points  between  melanoma  and 
non-melanoma skin cancer, it is a powerful feature to 
depend on when recognizing images.
Using neural networks to diagnose  
skin cancer type
Image  processing  finding  features  for  each  image 
from F1 to F20 were entered into the hierarchal NN 
system, and learned the network for the study selected 
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Table 2. Skin cancer number of images.
cancer type number of images
Melanoma
Superficial spreading melanoma 16
Nodular melanoma 9
Lintigo maligna melanoma 10
Acral lentiginous melanoma 4
non-melanoma
Basal cell carcinoma 10
Squamous cell carcinoma 7
Other types of non-melanoma
Sebaceous gland carcinoma 2Salah et al
6  Cancer Informatics 2011:10
types of skin cancer, and then neural networks were 
saved to be used for testing later.
It  is  known  that  cancer  in  general  is  proved 
through clinical tests not through the image of the 
tumor. A sample of a total of 58 images were taken 
from clinically proven skin cancer type images, and 
these images were classified into groups. The total 
number of the study images is 58 divided as shown 
in Table 2
Hierarchal NN systems involve the integration of 
four distinct neural networks that are trained sepa-
rately using a back propagation learning algorithm. 
Each  neural  network  has  twenty  neurons  in  input 
layer, nine neurons in first hidden layers, five neurons 
in second hidden layer, and an output layer with one 
neuron as shown In Figure 10. One thousand iterations 
for each NN are performed in order to have accurate 
results. Tan-sigmoid transfer function used to generate 
output.
Twenty  extracted  features  are  used  as  networks 
inputs.  NN1  is  trained  over  whole  data  to  deter-
mine the main type of the cancer: melanoma or non- 
melanoma, while NN2 trained over melanoma skin 
cancer images only to determine the type of mela-
noma skin cancer. 
NN3 is trained over non-melanoma skin cancer 
images.  It  checks  the  type  of  non-melanoma  and 
determines if it is the non-melanoma skin cancer type 
or other types of non-melanoma (Sebaceous gland 
carcinoma.) NN4 is trained over non-melanoma skin 
cancer images and it is used to determine the type 
of non-melanoma skin cancer. A proposed hierarchi-
cal NN system structure is shown in Figure 11, and 
Table 3 shows each neural network output ranges and 
results.
Each network is learned separately by taking 80% 
of the images as training data, and 20% as testing data. 
In some types of cancers, 50% of data are considered 
as learning, and 50% as testing, such as Sebaceous 
Gland Carcinoma since only two images for this type 
are available. Each network is learned 20 times with 
different input and testing data.
Using Neuro-Fuzzy to diagnose skin 
cancer type
Neuro-Fuzzy is one field of artificial intelligence; it 
is a combination of neural networks and fuzzy logic, 
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Figure 10. Basic neural networks structure.
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Figure 11. hierarchal neural network.
Table 3. hierarchical NN output ranges and results.
skin cancer type Ranges of results
nn1
Melanoma skin cancer -0.5 <= output , 0.5
Non-melanoma skin cancer 0.5 <= output , 1.5
nn2
Superficial spreading melanoma 0.5 <= output , 1.5
Nodular melanoma 1.5 <= output , 2.5
Lintigo maligna melanoma 2.5 <= output , 3.5
Acral lentiginous melanoma 3.5 <= output , 4.5
nn3
Sebaceous gland carcinoma -0.5 <= output , 0.5
Non-melanoma skin cancer 0.5 <= output , 1.5
nn4
Basal cell carcinoma -0.5 <= output , 0.5
Squamous cell carcinoma 0.5 <= output , 1.5Skin cancer diagnosis by neuro-fuzzy system
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with the object of having human-like reasoning style 
of fuzzy systems with the learning of neural networks. 
Neuro-fuzzy systems combine the human-like reason-
ing style of fuzzy systems through the use of fuzzy 
sets, and a linguistic model consisting of a set of IF-
THEN fuzzy rules. The main strength of neuro-fuzzy 
systems is that they are universal approximations with 
the ability to use IF-THEN rules.
After testing sample study images using hierar-
chal NN and extracting the results, the output is vali-
dated by using the neuro-fuzzy system that combines 
NN and fuzzy logic, which leads to high accurate 
results.
Fuzzy  logic  uses  validation  rules  that  control 
the output; these rules give a range of input and 
output.
The proposed fuzzy logic system checks its rules 
over the output of all Neural Networks. The output 
of NN1 and NN2 will be the input of the first Fuzzy 
Logic Inference System 1 (FIZ1), the output of FIZ1 
will be melanoma or non-melanoma, and the type of 
melanoma, if the output is non-melanoma, the sys-
tem enters the next Fuzzy Logic Inference System 2 
(FIZ2), where it checks whether the type of the skin 
cancer is non-melanoma type or other type of non-
melanoma, if the result is other type of non-mela-
noma (Sebaceous Gland Carcinoma), then the system 
ends, while if the result is non-melanoma, then the 
system enters Fuzzy Logic Inference System 3 (FIZ3) 
NN1, NN2
F1
Melanoma skin
cancer type
Non-melanoma
skin cancer
Non-melanoma skin cancer
NN1, NN2 (BCC, SCC) Other types of non-melanoma
skin cancer
Non-melanoma skin
cancer type
NN1, NN3
F2
NN1, NN3, NN4
F3
Figure 12. Structure of fuzzy logic system.
Table 4. FIZ1 Linguistic rules.
nn1 value nn2 value FIZ1 output
0.5 <= NN1 , 1.5 0.5 <= NN2 , 1.5 0.5 <= FIZ1 , 1.5
0.5 <= NN1 , 1.5 1.5 <= NN2 , 2.5 1.5 <= FIZ1 , 2.5
0.5 <= NN1 , 1.5 2.5 <= NN2 , 3.5 2.5 <= FIZ1 , 3.5
0.5 <= NN1 , 1.5 2.5 <= NN2 , 3.5 3.5 <= FIZ1 , 4.5
else else FIZ1 , 0.5
Table 5. FIZ2 Linguistic rules.
nn1 value nn3 value FIZ2 output
-0.5 <= NN1 , 0.5 -0.5 <= NN3 , 0.5 -0.5 <= FIZ2 , 0.5
-0.5 <= NN1 , 0.5 0.5 <= NN3 , 1.5 0.5 <= FIZ2 , 1.5
to determine the correct type of non-melanoma skin 
cancer. Figure 12 shows the structure of our Fuzzy 
Logic system.
The output of NN1 and NN2 is used as inputs 
of FIZ1. It determines if the cancer is mela-
noma or non-melanoma, and the type of mela-
noma. Table 4 illustrates linguistic rules used 
in FIZ1.
FIZ2 is used if the output of FIZ1 is non-mela-
noma skin cancer. Table 5 illustrates FIZ2 linguistic 
rules, it uses NN1 and NN3 outputs as input data. It 
determines the type of the non-melanoma skin cancer 
as shown in Table 6.
FIZ3 is used to determine the type of non-mel-
anoma skin cancer if FIZ2 output between 0.5 and 
1.5. Its input is the output of NN1, NN3 and NN4, 
Table 7 describes ranges of output regards each input 
values.
Results
The average results of neural networks system testing 
are shown in the Table 8.
As shown in this table, NN1 has the largest suc-
cess percentage, since all images are used as train-
ing  data,  while  NN3  has  the  lowest  percentage, 
which means that increasing the sample volume may 
improve the results. Image type has an impact on the 
results, such as the quality of the image, size of the 
tumor compared with other images, and variances in 
skin color. 
The result of the neuro-fuzzy system is shown 
in Table 4. If the output of NN1 is between 0.5 and Salah et al
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appear to occur owing to a close value of all features 
for most of the image data, noting that the types 
of skin cancer with fewer images have the same or 
close error rate compared to the Hierarchical NN 
system.
The  overall  success  rate  was  (91.26%)  which 
is  slightly  higher  than  the  hierarchal  NN  alone 
(90.76%). This increase (0.5%) is not significant; 
this  might  be  due  to  few  studied  images  in  the 
system.
Ten experiments were performed to calculate 
the success rate of diagnosis various types of can-
cer by using Hierarchical Neural Network system, 
while  only  one  experiment  was  done  by  using 
Neuro-Fuzzy  system.  Table  10  describes  these 
results.
Figure 13 shows the diagnostic results of 
Hierarchical  Neural  Network,  and  Neuro-Fuzzy 
systems. As we can see, number of correct diag-
nostic  images  by  Neuro-Fuzzy  system  is  more 
than the number diagnosis by Hierarchical Neural 
Network.
The  worst  results  were  in  the  diagnosis  of 
squamous cell carcinoma, which might be due to the 
small  number  of  squamous  cell  carcinoma  cancer 
images.
Discussion
In the fight against melanoma, a diagnostic aid from 
new  technologies  could  be  useful.  However,  the 
Table 6. Neuro-Fuzzy system output ranges and results.
skin cancer type Ranges of results
FIZ1
Superficial spreading melanoma 0.5 <= output , 1.5
Nodular melanoma 1.5 <= output , 2.5
Lintigo maligna melanoma 2.5 <= output , 3.5
Acral lentiginous melanoma 3.5 <= output , 4.5
Non-melanoma skin cancer else
FIZ2
Sebaceous gland carcinoma -0.5 <= output , 0.5
Non-melanoma skin cancer type 0.5 <= output , 1.5
FIZ3
Basal cell carcinoma -0.5 <= output , 0.5
Squamous cell carcinoma 0.5 <= output , 1.5
Table 7. FIZ3 Linguistic rules.
nn1 value nn3 value nn4 value FIZ1 output
-0.5<=  
NN1
0.5 <=  
NN3
-0.5 <=  
NN4
-0.5 <=  
FIZ3
And And And And
NN1 , 0.5 NN3 , 1.5 NN4 , 0.5 FIZ3 , 0.5
-0.5 <=  
NN1
0.5 <=  
NN3
0.5 <=  
NN4
0.5 <=  
FIZ3
And And And And
NN1 , 0.5 NN3 ,  
1.5
NN4 , 1.5 FIZ3 , 1.5
1.5, the cancer is melanoma, and if the output of 
NN2 is between 0.5 and 1.5, then the cancer type 
will  be  Superficial  Spreading  Melanoma,  which 
will be the output of FIZ1. All other skin cancer 
types will be known in the same way. Table 9 illus-
trates the output values of Neuro-Fuzzy System and 
their meaning.
All studied images were tested by using pro-
posed Neuro-Fuzzy system. First, hierarchical NN 
is  used  to  generate  outputs  regards  each  image, 
second, NN outputs used as inputs to Fuzzy Logic 
Inference  systems  as  mentioned  above.  Table 
10 shows the results of the Neuro-Fuzzy system. 
Accordingly  overall  success  percentage  of  diag-
nosing skin cancer type by using the Neuro-Fuzzy 
system is 91.26%, which is greater than hierarchal 
NN results.
As shown in Table 9, by using the Neuro-Fuzzy 
system the number of failed diagnostic images is 
very low: five out of fifty eight images. Failed tests 
Table 8. NN testing success percentage.
nn Training  
images
Testing  
images
success 
average
NN1 51 7 94.3%
NN2 35 4 87.5%
NN3 17 2 85%
NN4 15 2 90%
Table 9. Neuro-Fuzzy testing success percentage.
Fuzzy system Failed images success average
FIZ1 1 97.4%
FIZ2 0 100%
FIZ3 4 76.4%Skin cancer diagnosis by neuro-fuzzy system
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effective  reliability  of  computer-aided  systems  has 
still to be assessed.17,18 In this study we have explored 
the opportunity of using multispectral analysis and an 
NN and neuro fuzzy system in an attempt to mimic 
the decision of an expert clinician.
The  80%  specificity  with  the  resulting  88% 
sensitivity  is  an  arbitrary  value  and  could  be 
considered more or less satisfactory, depending 
on the accuracy usually assigned to physicians 
in  identifying  pigmented  lesions  suggestive  of 
melanoma.
Several research efforts have focused in the last 
few  years  on  the  possibility  of  introducing  into 
daily clinical practice computer aided classification 
or automatic machine vision to increase the accu-
racy  of  melanoma  diagnosis.19–26  In  fact,  although 
dermoscopy  seems  to  have  a  discriminant  power 
significantly  higher  than  clinical  examination  in 
classifying pigmented lesions, as documented in a 
recent meta-analysis,34 the accuracy of dermoscopy is 
highly variable across   different studies and is still far 
from the desirable   levels of 100% sensitivity and high 
specificity.
Sources of variation are likely to arise from 
differences in sample sizes, proportion of mel-
anomas in the sample, type of instrument used, 
dermoscopic criteria used, and, last but not least, 
human  variability  in  feature  recognition  and 
coding.
Our study provides an important contribution to 
this research area, since it is applied to all known 
types of skin cancer and because it highlights the 
importance of factors such as classifier design and 
feature  selection  in  computer  aided  diagnosis  that 
are generally overlooked in the previously published 
studies.
We  adopted  a  very  conservative  procedure  in 
feature selection for the linear classifier to obtain 
a relatively small set of robust parameters to dis-
criminate  melanoma  and  non  melanoma  types. 
This strategy and the use of a hold-out (separate 
training and test sets) design allowed performance 
estimates that were likely conservatively biased.35 
Despite this, the performances of the linear classi-
fiers were remarkably accurate, with a mean sensi-
tivity of 95%, a mean specificity of 88% and was 
highly stable on sets of lesions derived from differ-
ent dermatology centres, where the referral criteria 
for patients with pigmented lesions and the operat-
ing conditions of the instruments could have been 
different.
The most critical requirement of the NN and 
neuro  fuzzy  classifiers  is  to  have  a  training  set 
including enough examples of each class of pig-
mented  lesions  to  adequately  represent  the  full 
range of measurements that can be expected from 
each class.
Comparing the performances of the two classifiers, 
the neuro fuzzy approach, yielding a sensitivity of 
98% and a specificity of 89%, seemed to give results 
0
1 2 3 4
Skin cancer type
N
u
m
b
e
r
 
o
f
 
i
m
a
g
e
s
5 6 7
Total images NN success images Fuzzy success images
2
4
6
8
10
12
14
16
Figure 13. hierarchical NN and Neuro-Fuzzy comparison.
Table 10. Number of failed testing images.
cancer type neuro-Fuzzy 
system 
failed 
testing 
images
Hierarchical 
neural 
network failed 
testing images
Superficial spreading 
melanoma
0 0
Nodular melanoma 1 1
Lintigo maligna 
melanoma
0 1
Arcal lentignious 
melanoma
0 1
Basal cell  
carcinoma
1 2
Squamous cell  
carcinoma
3 4
Sebaceous gland 
carcinoma
0 1Salah et al
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similar to the NN approach (which gave sensitivity 
of 95% and specificity of 88%). Although the bottom 
line in the diagnosis of melanoma is likely to continue 
to depend on the clinical insight of the physician and 
on the expertise of the pathologist, computer-aided 
diagnosis could provide clinicians an objective sec-
ond opinion, at expert level, based on consistently 
extracting  and  analyzing  image  features.  To  what 
extent the combination of human and machine-based 
diagnoses would affect the decision-making process 
in the management of patients with pigmented lesions 
by improving the detection of early melanoma and/or 
decreasing unnecessary surgery remains to be evalu-
ated by well-designed, randomized clinical trials in 
the field.
conclusion and Future Works
After  testing  the  studied  sample  of  images  on  the 
two systems included in this research, the automatic 
image  processing  of  skin  cancer  found  is  difficult 
because of the different features of human skin, i.e, 
the skin pigmentation or color variations. The most 
dependable feature to recognize the type of image is 
the red color.
The results of testing the studied sample of images 
by using hierarchal NN system gave 90.67%, accu-
racy,  while  using  neuro-fuzzy  system  gave  better 
results than using the hierarchal NN system alone, 
with accuracy rate of 91.26%.
Image processing is the primary foundation of 
this study, and the concept of improving the means 
of extracting features of the skin image is the main 
recommendation for researchers to follow in the 
future.  The  output  of  both  hierarchal  NN  and 
neuro-fuzzy  systems  depends  on  these  features. 
The more accurate these feature are, the better the 
results will be.
Image normalization in our research was man-
ual,  and  in  future  work  it  is  recommended  that 
this  is  computerized.  Benign  cancers  should  be 
studied and distinguished in relation to that, and 
the proposed system can be compared with other 
systems.
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